– Director of Market Access

“The team at MORSE provided a comprehensive overview of the gene therapy landscape in Canada across the relevant stakeholders including Health Canada, CADTH, INESSS, provincial payers and private payers. They were able to leverage the strong expertise of their in-house team, as well as their external strategic partners, to provide diverse and informed insights about every step of the process. They were flexible and adaptable as the project scope evolved and delivered a highly detailed, informative, and interactive presentation of their findings. The outputs of this project have proven to be highly valuable in helping our organization better prepare for the opportunities and challenges of bringing novel gene therapies to Canada.”